Updated
EnovisENOV · Healthcare
$27.16-5.10%
Market cap$1.6B
IndustryMedical Devices

Enovis (ENOV) Superinvestor holders

16 of the superinvestors we track hold Enovis (ENOV) in their latest 13F filings, $55M in total.

Summary

The largest holder is Cliff Asness (AQR Capital Management), with $12M, 0.0% of the portfolio.

In their latest quarter: 2 opened a new position, 6 added, 5 trimmed.

Who holds it

Each investor's latest 13F filing, largest stake first. What a 13F shows.

InvestorLast changeSharesValue% of portfolioFiled for
Cliff Asness
AQR Capital Management
Added 590,647$12M 0.0%Q2 2026
Man Group
Man Group plc
Trimmed 420,821$9M 0.0%Q2 2026
Fred DiSanto
Ancora Holdings
Trimmed 337,144$7M 0.1%Q2 2026
Claus Moller
P2 Capital Partners
Held 320,000$7M 2.7%Q2 2026
Paul Marshall
Marshall Wace
Added 294,445$6M 0.0%Q2 2026
Arrowstreet Capital New position 284,431$6M 0.0%Q2 2026
Acadian
Acadian Asset Management
Added 118,800$2M 0.0%Q3 2026
David Shaw
D. E. Shaw & Co.
Trimmed 83,796$2M 0.0%Q2 2026
Ray Dalio
Bridgewater Associates
Added 77,088$2M 0.0%Q2 2026
Mason Hawkins
Southeastern Asset Management
Held 44,258$916,141 0.0%Q2 2026
Paul Tudor Jones
Tudor Investment Corp
Trimmed 25,167$520,957 0.0%Q2 2026
Josef Lakonishok
LSV Asset Management
Held 26,000$475,000 0.0%Q3 2026
Ken Tropin
Graham Capital Management
New position 17,088$353,722 0.0%Q2 2026
Alan Howard
Brevan Howard
Trimmed 14,891$308,244 0.0%Q2 2026
Mario Gabelli
GAMCO Investors
Added 14,243$294,830 0.0%Q2 2026
Ensign Peak
Ensign Peak Advisors
Added 5,284$109,379 0.0%Q2 2026

Holders by quarter

QuarterSuperinvestors holding it
Q2 202617
Q1 202615
Q4 202513
Q3 202515
Q2 202516
Q1 202514
Q4 202418
Q3 202420

Questions about Enovis

Which superinvestors own Enovis?

16 of the superinvestors we track hold Enovis (ENOV) in their latest 13F filings, $55M in total. Cliff Asness, Man Group, Fred DiSanto, Claus Moller, Paul Marshall, Arrowstreet Capital.

Who is the largest superinvestor holder of ENOV?

The largest holder is Cliff Asness (AQR Capital Management), with $12M, 0.0% of the portfolio.

From Enovis's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.

Investingly

Better research starts here.

Every filing, chart and insider trade behind Enovis and thousands of other companies, in one place. Free to start.